Tumour Angiogenesis

Dear Colleagues,

Tumor angiogenesis is critical for both tumor progression and metastasis. Hence targeting tumor angiogenesis as a therapeutic anticancer approach has been actively pursued for many years. Despite the initial success in animal tumor models and some degree of effectiveness in prolonging the survival of human cancer patients, limitations of efficacy plus inherent as well as acquired resistance in human cancers still plague this therapeutic approach. Hence, further understanding of the molecular and cellular mechanisms of tumor angiogenesis are essential for the advancement of effective antiangiogenic therapy. This special issue will focus on new advancement in the biology and drug targeting of tumor angiogenesis.

We are looking forward to your contributions.

Dr. Ruowen Ge
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.